Selected research
Industry Research
EO Residual Testing Industry Research Report 2026
Market perspective
The global EO Residual Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the EO Residual Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the EO Residual Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the EO Residual Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of EO Residual Testing include Eurofins Scientific, Nelson Labs, Steris, JordiLabs, LLC, TÜV SÜD, UFAG LABORATORIEN AG, Europejski Instytut Biomedyczny, SaniChem and Millstone Medical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global EO Residual Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to EO Residual Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
EO Residual Testing Market by Company
Eurofins Scientific
Nelson Labs
Steris
JordiLabs, LLC
TÜV SÜD
UFAG LABORATORIEN AG
Europejski Instytut Biomedyczny
SaniChem
Millstone Medical
Medistri
Auriga Research
Pace Analytical
STEMart
MCI
EO Residual Testing Segment by Type
Brief Contact（up to 24 Hour）
Long Term Contact（more than 1 Days）
EO Residual Testing Segment by Application
Pharmaceuticals
Medical Devices
Food Products
Others
EO Residual Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EO Residual Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EO Residual Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EO Residual Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of EO Residual Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brief Contact（up to 24 Hour）
- Long Term Contact（more than 1 Days）
Applications
- Pharmaceuticals
- Medical Devices
- Food Products
- Others
Companies covered
- Eurofins Scientific
- Nelson Labs
- Steris
- JordiLabs, LLC
- TÜV SÜD
- UFAG LABORATORIEN AG
- Europejski Instytut Biomedyczny
- SaniChem
- Millstone Medical
- Medistri
- Auriga Research
- Pace Analytical
- STEMart
- MCI
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 EO Residual Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Brief Contact（up to 24 Hour）
- 2.2.3 Long Term Contact（more than 1 Days）
- 2.3 EO Residual Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals
- 2.3.3 Medical Devices
- 2.3.4 Food Products
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 EO Residual Testing Breakdown Data by Type
- 3.1 Global EO Residual Testing Historic Market Size by Type (2021-2026)
- 3.2 Global EO Residual Testing Forecasted Market Size by Type (2027-2032)
4 EO Residual Testing Breakdown Data by Application
- 4.1 Global EO Residual Testing Historic Market Size by Application (2021-2026)
- 4.2 Global EO Residual Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global EO Residual Testing Market Perspective (2021-2032)
- 5.2 Global EO Residual Testing Growth Trends by Region
- 5.2.1 Global EO Residual Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 EO Residual Testing Historic Market Size by Region (2021-2026)
- 5.2.3 EO Residual Testing Forecasted Market Size by Region (2027-2032)
- 5.3 EO Residual Testing Market Dynamics
- 5.3.1 EO Residual Testing Industry Trends
- 5.3.2 EO Residual Testing Market Drivers
- 5.3.3 EO Residual Testing Market Challenges
- 5.3.4 EO Residual Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top EO Residual Testing Players by Revenue
- 6.1.1 Global Top EO Residual Testing Players by Revenue (2021-2026)
- 6.1.2 Global EO Residual Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global EO Residual Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of EO Residual Testing Head Office and Area Served
- 6.4 Global EO Residual Testing Players, Product Type & Application
- 6.5 Global EO Residual Testing Manufacturers Established Date
- 6.6 Global EO Residual Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America EO Residual Testing Market Size (2021-2032)
- 7.2 North America EO Residual Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America EO Residual Testing Market Size by Country (2021-2026)
- 7.4 North America EO Residual Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe EO Residual Testing Market Size (2021-2032)
- 8.2 Europe EO Residual Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe EO Residual Testing Market Size by Country (2021-2026)
- 8.4 Europe EO Residual Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific EO Residual Testing Market Size (2021-2032)
- 9.2 Asia-Pacific EO Residual Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific EO Residual Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific EO Residual Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America EO Residual Testing Market Size (2021-2032)
- 10.2 South America EO Residual Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America EO Residual Testing Market Size by Country (2021-2026)
- 10.4 South America EO Residual Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa EO Residual Testing Market Size (2021-2032)
- 11.2 Middle East & Africa EO Residual Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa EO Residual Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa EO Residual Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in EO Residual Testing Business (2021-2026)
- 12.1.4 Eurofins Scientific EO Residual Testing Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 Nelson Labs
- 12.2.1 Nelson Labs Company Information
- 12.2.2 Nelson Labs Business Overview
- 12.2.3 Nelson Labs Revenue in EO Residual Testing Business (2021-2026)
- 12.2.4 Nelson Labs EO Residual Testing Product Portfolio
- 12.2.5 Nelson Labs Recent Developments
- 12.3 Steris
- 12.3.1 Steris Company Information
- 12.3.2 Steris Business Overview
- 12.3.3 Steris Revenue in EO Residual Testing Business (2021-2026)
- 12.3.4 Steris EO Residual Testing Product Portfolio
- 12.3.5 Steris Recent Developments
- 12.4 JordiLabs, LLC
- 12.4.1 JordiLabs, LLC Company Information
- 12.4.2 JordiLabs, LLC Business Overview
- 12.4.3 JordiLabs, LLC Revenue in EO Residual Testing Business (2021-2026)
- 12.4.4 JordiLabs, LLC EO Residual Testing Product Portfolio
- 12.4.5 JordiLabs, LLC Recent Developments
- 12.5 TÜV SÜD
- 12.5.1 TÜV SÜD Company Information
- 12.5.2 TÜV SÜD Business Overview
- 12.5.3 TÜV SÜD Revenue in EO Residual Testing Business (2021-2026)
- 12.5.4 TÜV SÜD EO Residual Testing Product Portfolio
- 12.5.5 TÜV SÜD Recent Developments
- 12.6 UFAG LABORATORIEN AG
- 12.6.1 UFAG LABORATORIEN AG Company Information
- 12.6.2 UFAG LABORATORIEN AG Business Overview
- 12.6.3 UFAG LABORATORIEN AG Revenue in EO Residual Testing Business (2021-2026)
- 12.6.4 UFAG LABORATORIEN AG EO Residual Testing Product Portfolio
- 12.6.5 UFAG LABORATORIEN AG Recent Developments
- 12.7 Europejski Instytut Biomedyczny
- 12.7.1 Europejski Instytut Biomedyczny Company Information
- 12.7.2 Europejski Instytut Biomedyczny Business Overview
- 12.7.3 Europejski Instytut Biomedyczny Revenue in EO Residual Testing Business (2021-2026)
- 12.7.4 Europejski Instytut Biomedyczny EO Residual Testing Product Portfolio
- 12.7.5 Europejski Instytut Biomedyczny Recent Developments
- 12.8 SaniChem
- 12.8.1 SaniChem Company Information
- 12.8.2 SaniChem Business Overview
- 12.8.3 SaniChem Revenue in EO Residual Testing Business (2021-2026)
- 12.8.4 SaniChem EO Residual Testing Product Portfolio
- 12.8.5 SaniChem Recent Developments
- 12.9 Millstone Medical
- 12.9.1 Millstone Medical Company Information
- 12.9.2 Millstone Medical Business Overview
- 12.9.3 Millstone Medical Revenue in EO Residual Testing Business (2021-2026)
- 12.9.4 Millstone Medical EO Residual Testing Product Portfolio
- 12.9.5 Millstone Medical Recent Developments
- 12.10 Medistri
- 12.10.1 Medistri Company Information
- 12.10.2 Medistri Business Overview
- 12.10.3 Medistri Revenue in EO Residual Testing Business (2021-2026)
- 12.10.4 Medistri EO Residual Testing Product Portfolio
- 12.10.5 Medistri Recent Developments
- 12.11 Auriga Research
- 12.11.1 Auriga Research Company Information
- 12.11.2 Auriga Research Business Overview
- 12.11.3 Auriga Research Revenue in EO Residual Testing Business (2021-2026)
- 12.11.4 Auriga Research EO Residual Testing Product Portfolio
- 12.11.5 Auriga Research Recent Developments
- 12.12 Pace Analytical
- 12.12.1 Pace Analytical Company Information
- 12.12.2 Pace Analytical Business Overview
- 12.12.3 Pace Analytical Revenue in EO Residual Testing Business (2021-2026)
- 12.12.4 Pace Analytical EO Residual Testing Product Portfolio
- 12.12.5 Pace Analytical Recent Developments
- 12.13 STEMart
- 12.13.1 STEMart Company Information
- 12.13.2 STEMart Business Overview
- 12.13.3 STEMart Revenue in EO Residual Testing Business (2021-2026)
- 12.13.4 STEMart EO Residual Testing Product Portfolio
- 12.13.5 STEMart Recent Developments
- 12.14 MCI
- 12.14.1 MCI Company Information
- 12.14.2 MCI Business Overview
- 12.14.3 MCI Revenue in EO Residual Testing Business (2021-2026)
- 12.14.4 MCI EO Residual Testing Product Portfolio
- 12.14.5 MCI Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst